Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Dig Liver Dis. 2019 Feb 3;51(9):1330–1336. doi: 10.1016/j.dld.2019.01.017

Table 3.

Sensitivity, Specificity and c-statistics/AUC for Occurrence of Adverse Outcomes at 6 years According to Liver Score risk classes, Frailty, Sarcopenia and disability at baseline.

Sensitivity Specificity c-statistics (95%CI)
Death
NFS 0.24 0.88 0.6(0.57–0.63)
FIB-4 0.17 0.93 0.6(0.57–0.63)
BARD 0.15 0.89 0.53(0.5–0.56)
AST/ALT ratio 0.74 0.38 0.57(0.54–0.6)
FRAILTY 0.27 0.95 0.59(0.57–0.62)
SARCOPENIA 0.26 0.94 0.59(0.56–0.61)
BASELINE DISABILITY 0.17 0.98 0.56(0.54–0.58)
CV-death Sensitivity Specificity c-statistics (95%CI)
NFS 0.27 0.88 0.62(0.57–0.66)
FIB-4 0.16 0.94 0.61(0.56–0.65)
BARD 0.14 0.89 0.54(0.51–0.58)
AST/ALT ratio 0.83 0.38 0.6(0.56–0.63)
FRAILTY 0.37 0.95 0.63(0.59–0.67)
SARCOPENIA 0.34 0.94 0.6(0.55–0.64)
BASELINE DISABILITY 0.24 0.98 0.59(0.55–0.62)
Incident Disability Sensitivity Specificity AUC (95%CI)
NFS 0.21 0.89 0.57(0.51–0.62)
FIB-4 0.2 0.95 0.59(0.53–0.66)
BARD 0.11 0.89 0.53(0.5–0.56)
AST/ALT ratio 0.79 0.4 0.57(0.54–0.6)
FRAILTY 0.18 0.97 0.58(0.53–0.62)
SARCOPENIA 0.22 0.96 0.59(0.54–0.64)